Flavin Financial Services Inc. Acquires 2,629 Shares of UnitedHealth Group Incorporated $UNH

Flavin Financial Services Inc. grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 52.8% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 7,610 shares of the healthcare conglomerate’s stock after buying an additional 2,629 shares during the quarter. UnitedHealth Group accounts for approximately 1.9% of Flavin Financial Services Inc.’s portfolio, making the stock its 19th largest holding. Flavin Financial Services Inc.’s holdings in UnitedHealth Group were worth $2,628,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. Brighton Jones LLC boosted its position in UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after buying an additional 28,231 shares during the period. Revolve Wealth Partners LLC raised its stake in shares of UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after acquiring an additional 2,324 shares during the last quarter. CMT Capital Markets Trading GmbH bought a new stake in shares of UnitedHealth Group in the second quarter worth about $340,000. Vestmark Advisory Solutions Inc. raised its position in UnitedHealth Group by 16.0% during the 2nd quarter. Vestmark Advisory Solutions Inc. now owns 14,103 shares of the healthcare conglomerate’s stock valued at $4,400,000 after purchasing an additional 1,942 shares during the last quarter. Finally, Penserra Capital Management LLC grew its position in shares of UnitedHealth Group by 24.8% in the 2nd quarter. Penserra Capital Management LLC now owns 9,586 shares of the healthcare conglomerate’s stock worth $2,990,000 after buying an additional 1,902 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Price Performance

UNH opened at $286.86 on Monday. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $606.36. The stock has a 50-day moving average price of $308.28 and a 200-day moving average price of $326.02. The firm has a market cap of $260.38 billion, a PE ratio of 21.75, a P/E/G ratio of 1.32 and a beta of 0.41. The company has a debt-to-equity ratio of 0.72, a current ratio of 0.79 and a quick ratio of 0.79.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.09 by $0.02. UnitedHealth Group had a net margin of 2.69% and a return on equity of 14.79%. The business had revenue of $113.73 billion during the quarter, compared to analysts’ expectations of $113.38 billion. During the same period in the previous year, the company earned $6.81 earnings per share. The business’s revenue for the quarter was up 12.3% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. Sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 17th. Shareholders of record on Monday, March 9th will be issued a $2.21 dividend. The ex-dividend date of this dividend is Monday, March 9th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 3.1%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 67.02%.

Analysts Set New Price Targets

UNH has been the subject of several research reports. JPMorgan Chase & Co. decreased their price objective on shares of UnitedHealth Group from $425.00 to $389.00 and set an “overweight” rating for the company in a report on Monday, February 2nd. Evercore raised shares of UnitedHealth Group to a “strong-buy” rating in a research note on Tuesday, January 6th. Royal Bank Of Canada cut their price objective on UnitedHealth Group from $408.00 to $361.00 and set an “outperform” rating on the stock in a research report on Wednesday, January 28th. Oppenheimer lowered their target price on UnitedHealth Group from $415.00 to $385.00 and set an “outperform” rating for the company in a research note on Wednesday, January 28th. Finally, Sanford C. Bernstein reiterated an “outperform” rating on shares of UnitedHealth Group in a report on Wednesday, January 28th. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating, eight have issued a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $372.13.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.